Note 3 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) $ in Thousands |
6 Months Ended |
|---|---|
|
Dec. 31, 2019
USD ($)
| |
| Balance | $ 732,667 |
| Acquisitions (Note 4) | 0 |
| Currency translation | 1,574 |
| Balance | 734,241 |
| Protein Sciences [Member] | |
| Balance | 377,407 |
| Acquisitions (Note 4) | 0 |
| Currency translation | 1,609 |
| Balance | 379,016 |
| Diagnostics and Genomics [Member] | |
| Balance | 355,260 |
| Acquisitions (Note 4) | 0 |
| Currency translation | (35) |
| Balance | $ 355,225 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|